RO 600175

Drug Profile

RO 600175

Latest Information Update: 21 Mar 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antidepressants
  • Mechanism of Action Serotonin 2C receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Major depressive disorder; Obsessive-compulsive disorders

Most Recent Events

  • 21 Mar 2000 A study has been added to the Anxiety Disorders pharmacodynamics section
  • 08 Oct 1997 Discontinued-preclinical in Anxiety disorders in Switzerland (Unknown route)
  • 08 Oct 1997 Discontinued-preclinical in Depression in Switzerland (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top